Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02490124 · ClinicalTrials.gov registry record
The Effect of Type 1 Diabetes on Pan-Arterial Vascular Function and Insulin Sensitivity in Humans
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 7
- Enrollment target
NCT02490124: Completed study, sponsored by University of Virginia.
NCT02490124 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02490124 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
Arterial vascular disease is the major cause of morbidity and mortality for Type 1 diabetic patients (DM1). Metabolic insulin resistance (metIR), even in the absence of hyperglycemia, conveys a 1.5 to 3-fold increased CVD risk in the general population. Metabolic Insulin Resistance (MetIR) has been repeatedly shown to be prevalent in adults and adolescents with DM1. MetIR in obesity and DM2 are accompanied by vascular insulin resistance (vasIR) which is characterized by impaired vasodilatory action of insulin on resistance or microvascular vessels. VasIR has not been systematically studied in DM1. We hypothesize that in young adults DM1 impairs both baseline and insulin-responsive vascular function throughout the arterial vasculature.
Primary Outcome
vascular measure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-12 |
| Est. Completion | 2015-06 |
What the finished NCT02490124 record still lists
NCT02490124 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02490124 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02490124 about?
NCT02490124 is a clinical study titled "The Effect of Type 1 Diabetes on Pan-Arterial Vascular Function and Insulin Sensitivity in Humans". Arterial vascular disease is the major cause of morbidity and mortality for Type 1 diabetic patients (DM1). Metabolic insulin resistance (metIR), even in the absence of hyperglycemia, conveys a 1.5 to 3-fold increased CVD risk in the general population. Metabolic Insulin Resistance (MetIR) has been ...
What is the current status of trial NCT02490124?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2014-12. Estimated completion is 2015-06.
Who is sponsoring clinical trial NCT02490124?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia